The Menopause Society notes about 1 in 5 women aged 50 to 64 have used a GLP-1 drug, often for weight gain tied to menopause.
Recap by typeshit. Full story at U.S. News & World Report.
She describes MOTS-c as a messenger made by mitochondria that may help muscles handle sugar. The framing is hers and not an established health claim.
Medscape covers research tying GLP-1 drug use to lower alcohol consumption. Tap through for the study details and what researchers found.
In a small 2022 trial, whey beat leucine-boosted collagen for muscle growth, while evidence that collagen prevents sports injuries is still missing.
A retrospective study in Cureus looks back at how well once-weekly semaglutide worked, and how safe it was, for teenagers with obesity.
A new GLP-1 described as stronger than current options is being tested in trials, and researchers lay out what people should understand about it.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
Loading…